Desuzumab for knee osteoarthritis
Treatments studied
Part of Bones, joints & muscles clinical trials.
This study tests a new medicine called Desuzumab for knee osteoarthritis. It looks at whether the medicine can help reduce pain and improve joint function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 75 years old
- You have been diagnosed with knee osteoarthritis by a doctor
- You have not taken any medication that could affect the study results recently
- You do not have any serious health conditions like diabetes, thyroid problems, bone disease, or cancer
- You are willing to follow the study rules and come to all visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well different pain medicines work for knee osteoarthritis and looks at brain patterns to understand why some people get more relief. It may help you find a treatment that works best for you.
This study tests a small patch with a needle that delivers a medicine called denosumab through the skin. It is for healthy people or those with osteoarthritis and osteoporosis, to check if the patch is safe for the skin.
This study tests whether denosumab, a medication that strengthens bones, can also improve muscle strength and insulin sensitivity in postmenopausal women with type 2 diabetes who take metformin.
This study compares two treatment plans for women with osteoporosis to see which one improves hip bone density more. Participants will either get two medications in sequence (romosozumab followed by denosumab) or one medication (zoledronic acid), both given as injections or infusions. The goal is to find a treatment that reduces fracture risk.
This study tests a new antibody drug (FB1003) for people with knee osteoarthritis pain. It will check if the drug is safe and helps reduce pain. You may be eligible if you have moderate to severe knee pain and are willing to temporarily stop your usual pain medications.
This study tests whether denosumab, a medication given as an injection, can help prevent broken bones in people with type 2 diabetes who are at high risk for fractures. It aims to see if this treatment can strengthen bones and reduce fracture risk.
Hear when a new Knee Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.